Lakefront Biotherapeutics | GLPG - Market Capitalization

Stock Price
23.40
Daily Change
-0.38 -1.60%
Monthly
-5.26%
Yearly
-5.11%
Q2 Forecast
22.89

Lakefront Biotherapeutics reported EUR1.54B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
argenx SE USD 39.98B 4.4B May/2026
AstraZeneca USD 301.25B 13.1B Mar/2026
Biogen USD 26.9B 1.09B Mar/2026
Genmab DKK 20.48B 1.02B Dec/2025
Gilead Sciences USD 167.39B 5.6B May/2026
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
GRIFOLS EUR 3.69B 1.9B May/2026
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Incyte USD 21.73B 3B May/2026
Merck EUR 52.48B 826.08M May/2026
Neurocrine Biosciences USD 15.15B 1.9B May/2026
Novartis USD 232.75B 75B May/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.27B 605.48M Mar/2026
UCB EUR 46.41B 13.94B Dec/2025
Vertex Pharmaceuticals USD 113.58B 1000K May/2026